annual cash & cash equivalents:
$150.07M-$128.42M(-46.11%)Summary
- As of today (August 25, 2025), ABVX annual cash & cash equivalents is $150.07 million, with the most recent change of -$128.42 million (-46.11%) on December 31, 2024.
- During the last 3 years, ABVX annual cash & cash equivalents has risen by +$81.35 million (+118.36%).
- ABVX annual cash & cash equivalents is now -46.11% below its all-time high of $278.50 million, reached on December 31, 2023.
Performance
ABVX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$111.88M(NaN%)Summary
- As of today (August 25, 2025), ABVX quarterly cash & cash equivalents is $111.88 million
- ABVX quarterly cash & cash equivalents is now -59.83% below its all-time high of $278.50 million, reached on December 31, 2023.
Performance
ABVX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABVX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.1% | - |
| 3 y3 years | +118.4% | +826.1% |
| 5 y5 years | +1272.0% | +725.6% |
ABVX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.1% | +419.3% | -59.8% | +826.1% |
| 5 y | 5-year | -46.1% | +1272.0% | -59.8% | +2066.8% |
| alltime | all time | -46.1% | >+9999.0% | -59.8% | >+9999.0% |
ABVX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $111.88M(-59.8%) |
| Dec 2024 | $150.07M(-46.1%) | - |
| Dec 2023 | $278.50M(+863.6%) | $278.50M(+124.0%) |
| Jun 2023 | - | $124.30M(+330.1%) |
| Dec 2022 | $28.90M(-57.9%) | $28.90M(+139.2%) |
| Jun 2022 | - | $12.08M(-82.4%) |
| Dec 2021 | $68.73M(+90.7%) | $68.73M(+1231.0%) |
| Jun 2021 | - | $5.16M(-85.7%) |
| Dec 2020 | $36.03M(+229.4%) | $36.03M(+165.9%) |
| Jun 2020 | - | $13.55M(+23.9%) |
| Dec 2019 | $10.94M | $10.94M(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $13.13M(+43.6%) |
| Dec 2018 | $9.15M(+305.3%) | $9.15M(+207.5%) |
| Jun 2018 | - | $2.97M(+31.8%) |
| Dec 2017 | $2.26M(-73.1%) | $2.26M(+54.6%) |
| Jun 2017 | - | $1.46M(-82.6%) |
| Dec 2016 | $8.39M(+6349.4%) | $8.39M(+585.1%) |
| Jun 2016 | - | $1.22M(+841.4%) |
| Dec 2015 | $130.10K(-91.2%) | $130.10K(-99.8%) |
| Jun 2015 | - | $60.20M(+3954.5%) |
| Dec 2014 | $1.48M(-63.0%) | $1.48M |
| Dec 2013 | $4.02M | - |
FAQ
- What is ABIVAX Société Anonyme annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ABIVAX Société Anonyme?
- What is ABIVAX Société Anonyme annual cash & cash equivalents year-on-year change?
- What is ABIVAX Société Anonyme quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for ABIVAX Société Anonyme?
What is ABIVAX Société Anonyme annual cash & cash equivalents?
The current annual cash & cash equivalents of ABVX is $150.07M
What is the all time high annual cash & cash equivalents for ABIVAX Société Anonyme?
ABIVAX Société Anonyme all-time high annual cash & cash equivalents is $278.50M
What is ABIVAX Société Anonyme annual cash & cash equivalents year-on-year change?
Over the past year, ABVX annual cash & cash equivalents has changed by -$128.42M (-46.11%)
What is ABIVAX Société Anonyme quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ABVX is $111.88M
What is the all time high quarterly cash & cash equivalents for ABIVAX Société Anonyme?
ABIVAX Société Anonyme all-time high quarterly cash & cash equivalents is $278.50M